Cleared Traditional

Blood Pressure Monitor (K190207) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K190207 · Shenzhen Viatom Technology Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2019
Decision
196d
Days
Class 2
Risk

K190207 is an FDA 510(k) clearance for the Blood Pressure Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Shenzhen Viatom Technology Co., Ltd. (Shen Zhen, CN). The FDA issued a Cleared decision on August 19, 2019 after a review of 196 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen Viatom Technology Co., Ltd. devices

Submission Details

510(k) Number K190207 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 2019
Decision Date August 19, 2019
Days to Decision 196 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
71d slower than avg
Panel avg: 125d · This submission: 196d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Shenzhen Joyantech Consulting Co., Ltd.
Lucy Yan

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 279
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K190207.
CNAP Monitor
K183521 · Cnsystems Medizintechnik GmbH · Sep 2019
EV1000 Clinical Platform NI, EV1000 Clinical Platform
K192058 · Edwards Lifesciences, LLC · Aug 2019
Electronic Blood Pressure Monitor
K191180 · Shenzhen AOJ Medical Technology Co., Ltd. · Aug 2019
Non-invasive Hemodynamic Blood Pressure Monitor
K190893 · Vita-Course Technologies Co., Ltd. · Aug 2019
Med-link Wrist Digital Blood Pressure Monitor, Med-link Upper Arm Digital Blood Pressure Monitor
K181154 · Shenzhen Med-Link Electronics Tech Co., Ltd. · Aug 2019
Non-invasive blood pressure measurement systems
K190886 · Joytech Healthcare Co. , Ltd. · Jul 2019